Antisense oligonucleotide modulation of raf gene expression

Details Antisense oligonucleotide modulation of raf gene expression Antisense oligonucleotide modulation of raf gene expression

1995-06-02

1997-08-12

LeGuyader, John J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

435 6, 435 911, 435375, 536 231, 536 245, A61K 3170, C12N 1585, C07H 2100

Patent

active

056566123

ABSTRACT:
Oligonucleotides are provided which are targeted to nucleic acids encoding human c-raf and capable of inhibiting raf expression. The oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides. Methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided. The present invention further comprises methods of inhibiting hyperproliferation of cells and methods of treating abnormal proliferative conditions which employ oligonucleotides of the invention.

REFERENCES:
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5004810 (1991-04-01), Draper et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5135917 (1992-08-01), Burch
patent: 5166195 (1992-11-01), Ecker et al.
patent: 5194428 (1993-03-01), Agrawal et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5286717 (1994-02-01), Cohen et al.
Barinaga "Gene therapy for clogged arteries passes test in pigs" Science 265:738 Aug. 1994.
Bonner et al. "The complete coding sequence or the human raf oncogene and the corresponding structure of the c-raf-1 gene" Nucleic Acids Res. 14:1009-1015 1986.
Gura "Antisense has growing claims" Science 270: 575-577. Oct. 1995.
Sedlak "Mab treatment for for solid cancers remains more a question than a promise" Genetic Eng. News 16(9) 10-11. May 1, 1996.
Bennett et al., J. Clin. Invest. 1994, 93, 820-828.
BioWorld Today, Apr. 29, 1994, p. 3. It is thus.
Isobe et al., Circulation 1991, 84, 1246-1255.
Kingston, R.E., in Current Protocols in Molecular Biology, (F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman and K. Strahl, eds.), John Wiley and Sons, NY.
P.E. Nielsen, M. Egholm, R.H. Berg, O. Buchardt, Science 1991, 254, 1497.
Rapp et al., The Oncogene Handbook, E.P. Reddy, A.M Skalka and T. Curran, eds., Elsevier Science Publishers, New York, 1988, pp. 213-253.
Riedel et al., Eur. J. Immunol. 1993, 23, 3146-3150.
Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, pp. 10.59.
Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, pp. 11.31-11.32.
Tornkvist et al., J. Biol. Chem. 1994, 269, 13919-13921.

Affiliated with

Also associated with

Rating

Antisense oligonucleotide modulation of raf gene expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense oligonucleotide modulation of raf gene expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotide modulation of raf gene expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-160630